Effects of dopamine D1 receptor full agonists in rats trained to discriminate SKF 38393

Behavioural Pharmacology

Volumn 15, Issue 1, 2004, Pages 85-89

  Gleason, S D ^a   Witkin, J M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

D1 receptors; Drug discrimination; Rat; SKF 38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 4,5,5A,6,7,11B HEXAHYDRO 9,10 DIHYDROXY 2 PROPYL 3 THIA 5 AZACYCLOPENT 1 ENA[C]PHENANTHRENE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 9 HYDROXY 2,3,7,11B TETRAHYDRO 1H NAPH[1,2,3 DE]ISOQUINOLINE; ADROGOLIDE; DIHYDREXIDINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; DINAPSOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ISOQUINOLINE DERIVATIVE; NAPHTHOL DERIVATIVE; PHENANTHRIDINE DERIVATIVE; PRODRUG; PYRIDINE DERIVATIVE; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATION LEARNING; DISCRIMINATIVE STIMULUS; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; MALE; METHODOLOGY; NONHUMAN; RAT; TRAINING; ANIMAL; APPETITE; COMPARATIVE STUDY; DRUG INTERACTION; DRUG POTENTIATION; INSTRUMENTAL CONDITIONING; MOTIVATION; SPRAGUE DAWLEY RAT; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; APPETITIVE BEHAVIOR; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DRUG INTERACTIONS; ISOQUINOLINES; MALE; MOTIVATION; NAPHTHOLS; PHENANTHRIDINES; PRODRUGS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDRONAPHTHALENES;

EID: 1242317102     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200402000-00010     Document Type: Article

References (33)

1. Acri JB, Carter SR, Alling K, Geter-Douglass B, Dijkstra D, Wikstrom H, et al. (1995). Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. Eur J Pharmacol 281:R7-9.
2. Acri JB, Serdikoff SL, Witkin JM, Sannerud CA (1996). Discriminative stimulus effects of the benzodiazepine partial agonist bretazenil in pigeons and rats. Behav Pharmacol 7:72-77.
3. Andrews JS, Stephens DN (1991). Discriminative stimulus properties of the benzodiazepine receptor partial agonist β-carbolines abecarnil and ZK 95962: a comparison with chlordiazepoxide. Behav Pharmacol 2:171-185.
4. Bennett DA (1985). The non-sedating anxiolytic CGS 9896 produces discriminative stimuli that may be related to an anxioselective effect. Life Sci 37:703-709.
5. Brewster WK, Nichols DE, Riggs RM, Mottola DM, Lovenberg TW, Lewis MH, Mailman RB (1990). Trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydiobeno-[a] phenantridine: A highly potent selective dopamine D1 full agonist. J Med Chem 33:1756-1764.
6. Caine SB, Negus SS, Mello NK, Bergman J (1999). Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J Pharmacol Exp Ther 291:353-360.
7. Chausmer AL, Katz JL (2002). Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents. Psychopharmacology (Berl) 159:145-153.
8. Cunningham KA, Callahan PM, Appel JB (1985). Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393. Eur J Pharmacol 119:121-125.
9. Ghosh D, Snyder SE, Watts VJ, Mailman RB, Nichols DE (1996). 9-Dihydroxy-2, 3,7,11 b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore. J Med Chem 39:549-555.
10. Giardina WJ, Williams M (2001). Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data. CNS Drug Rev 7:305-316.
11. Gilmore JH, Watts VJ, Lawler CP, Noll EP, Nichols DE, Mailman RB (1995). 'Full' dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications. Neuropharmacology 34:481-488.
12. Gulwadi AG, Korpinen CD, Mailman RB, Nichols DE, Sit SY, Taber MT (2001). Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease. J Pharmacol Exp Ther 296:338-344.
13. Haile CN, Kosten TA (2001). Differential effects of D1- and D2-like compounds on cocaine self-administration in Lewis and Fischer 344 inbred rats. J Pharmacol Exp Ther 299:509-518.
14. Haile CN, Carey G, Varty GB, Coffin VL (2000). The dopamine D(1) receptor agonist SKF-82958 serves as a discriminative stimulus in the rat. Eur J Pharmacol 388:125-131.
15. Kamien JB, Woolverton WL (1985). The D1 dopamine agonist SKF 38393 functions as a discriminative stimulus in rats. Psychopharmacology (Berl) 87:368-370.
16. Katz JL, Alling KL (2000). Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats. Behav Pharmacol 11:483-493.
17. Katz JL, Witkin JM (1992). Selective effects of the D1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection. Psychopharmacology (Berl) 109:241-244.
18. Michaelides MR, Hong Y, DiDomenico S Jr, Asin KE, Britton DR, Lin CW, et al. (1995). (5aR, 11bS)-4,5,5a,6,7,11 b-Hexahydro-2-propyl-3-thia-5- azacyclopent-1-ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431). J Med Chem 38:3445-3447.
19. Michaelides MR, Hong Y, DiDomenico S Jr, Bayburt EK, Asin KE, Britton DR, et al. (1997). Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo. J Med Chem 40:1585-1599.
20. 3 agonist PD 128,907. J Pharmacol Exp Ther 275:1335-1366.
21. Reavill C, Bond B, Overend P, Hunter AJ (1993). Pharmacological characterization of the discriminative stimulus properties of the dopamine D1 agonist, SKF 81297. Behav Pharmacol 4:135-146.
22. Rosenzweig-Lipson S, Bergman J (1993). Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. J Pharmacol Exp Ther 267:765-775.
23. Schechter MD (1995). The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat. Psychopharmacology (Berl) 119:79-84.
24. 1 receptor agonist ABT-432 on cocaine self-administration and reinstatement. Ann NY Acad Sci 909:133-144.
25. Shiosaki K, Jenner P, Asin KE, Britton DR, Lin CW, Michaelides M, et al. (1996). ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease. J Pharmacol Exp Ther 276:150-160.
26. Spealman RD, Bergman J, Rosenzweig-Lipson S (1997). Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists. Psychopharmacologia 13:283-292.
27. Taylor JR, Lawrence MS, Redmond DE Jr, Elsworth JD, Roth RH, Nichols DE, Mailman RB (1991). Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. Eur J Pharmacol 9:389-391.
28. Walker E, Young A (1993). Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. J Pharmacol Exp Ther 267:322-330.
29. Williams JE, Woolverton WL (1990). The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393. Pharmacol Biochem Behav 37:289-293.
30. Witkin JM, Nichols DE, Terry P, Katz JL (1991). Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713.
31. Witkin JM, Acri JB, Wong G, Gleeson S, Barrett JE (1996). Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons. J Pharmacol Exp Ther 277:87-96.
32. Woolverton WL, Kamien JB, Goldberg LI (1995). Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline. Pharmacol Biochem Behav 22:577-581.
33. Young AM, Masaki MA, Geula C (1992). Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmcol Exp Ther 261:246-257.